| 1812890-23-5 Basic information More.. |
Product Name: | 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine | Synonyms: | 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine;Tofacitinib Related Compound 23;5H-Pyrrolo[2,3-d]pyrimidin-4-amine, 6,7-dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;Azilsartan medoxomil impurity319;Tofacitinib Hydrogenation Impurities;(6,7-Dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl)-methyl-(4-methyl-piperidin-3-yl)-amine;Tofatinib Impurity 17;N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity) | CAS: | 1812890-23-5 | MF: | C13H21N5 | MW: | 247.34 | EINECS: | | Mol File: | 1812890-23-5.mol | ![1812890-23-5](/CAS/20180703/GIF/1812890-23-5.gif) |
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine manufacturers
- Tofacitinib Impurity 17
-
- US $0.00-0.00 / mg
- 2024-05-20
- CAS:1812890-23-5
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
|
1812890-23-5
Recommend Suppliers |
|